MedPath

Clinical study for the treatment of perimenopausal syndrome with the method of rank-side perforation.

Phase 1
Recruiting
Conditions
Perimenopausal syndrome
Registration Number
ITMCTR1900002376
Lead Sponsor
The Third Hospital of Shanxi College of Traditional Chinese Medicine ( Shanxi Provincial Acupuncture and Moxibustion Hospital)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Comply with the diagnostic criteria for peri-menopausal syndrome in Western medicine;
(2) Comply with the diagnostic criteria for peri-menopausal syndrome in Chinese medicine;
(3) Baseline heating score = 4 points;
(4) Informed and agreed to participate in the study.

Exclusion Criteria

(1) uterine and ovarian organic lesions; after ovarian, hysterectomy or local radiotherapy;
(2) Those who have a pregnancy or are pregnant in the near future;
(3) Currently receiving other therapies to treat the disease;
(4) Patients with severe liver and kidney dysfunction, infectious diseases, cardiovascular and cerebrovascular diseases, and mental illness;
(5) Those who have used sex hormones in the past 3 months.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum sex hormone levels;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath